Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/Bc9e7c4177cc8b0bfc810e090d390d86e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- Bc9e7c4177cc8b0bfc810e090d390d86e NCIT_P378 "NCI" @default.
- Bc9e7c4177cc8b0bfc810e090d390d86e type Axiom @default.
- Bc9e7c4177cc8b0bfc810e090d390d86e annotatedProperty IAO_0000115 @default.
- Bc9e7c4177cc8b0bfc810e090d390d86e annotatedSource NCIT_C173729 @default.
- Bc9e7c4177cc8b0bfc810e090d390d86e annotatedTarget "A recombinant human adenoviral (rAd)-based vaccine encoding for the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike glycoprotein (SP), with potential immunomodulating and anti-COVID-19 activities. Gam-COVID-Vac contains two components: a rAd type 26 (rAd26) prime component encoding the SARS-CoV-2 S protein gene and a rAd type 5 (rAd5) boost component encoding the SARS-CoV-2 S protein gene. Upon intramuscular administration of the Gam-COVID-Vac, the Ad infects cells and produces SP. The released SP activates the immune system to induce a humoral and cell-mediated immune response against SARS-CoV-2. This may prevent SARS-CoV-2 infection and inhibit viral replication. SP, usually found on the surface of SARS-CoV-2, plays an essential role in the infection pathway of the SARS-CoV-2 virus." @default.